Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery

ClinicalTrials.gov ID: NCT01127581

Public ClinicalTrials.gov record NCT01127581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Double-blind, Randomized, Multicenter Study of Exogenous Prostaglandin Comparing the Efficacy & Safety of the MVI 200 mcg Versus the Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery in Pregnant Women at Term

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether the Misoprostol Vaginal Insert (MVI) 200 microgram (mcg) can decrease the time to vaginal delivery compared to the Dinoprostone Vaginal Insert (DVI) 10 milligram (mg) in pregnant women requiring cervical ripening and induction of labor.

Study identification

NCT ID
NCT01127581
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
1,358 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Mar 2012 (Actual)
Completion
Mar 2012 (Actual)
Last update posted
May 1, 2014

2010 – 2012

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
Maricopa Medical Center - District Medical Group Phoenix Arizona — —
Precision Trials Phoenix Arizona — —
Phoenix Perinatal Associates (Scottsdale Healthcare Shea) Scottsdale Arizona — —
Watching Over Mothers and Babies Foundation Tucson Arizona — —
Miller's Childrens Hospital Long Beach California — —
UCI Medical Center Orange California — —
The Women's Clinic of Northern Colorado Fort Collins Colorado — —
Christiana Care Health System (DE Center for MFM) Newark Delaware — —
University of FL College of Medicine Jacksonville Florida — —
Altus Research Lake Worth Florida — —
University of South Florida Tampa Florida — —
Indiana University School of Medicine Indianapolis Indiana — —
University of Kansas School of Medicine Kansas City Kansas — —
University of Michigan Hospital Ann Arbor Michigan — —
Spectrum Health Grand Rapids Michigan — —
St. Louis University St Louis Missouri — —
St. Peters University Hospital New Brunswick New Jersey — —
University of New Mexico/New Mexico Health Science Center Albuquerque New Mexico — —
Duke University Medical Center Durham North Carolina — —
East Carolina University, Brody School of Medicine Greenville North Carolina — —
Lyndhurst Gynecologic Associates Winston-Salem North Carolina — —
University of Cincinnati Cincinnati Ohio — —
Clinical Trials of America Eugene Oregon — —
Drexel University College of Medicine Philadelphia Pennsylvania — —
Temple University School of Medicine Philadelphia Pennsylvania — —
Thomas Jefferson University Philadelphia Pennsylvania — —
Medical University of South Carolina Charleston South Carolina — —
University Medical Group/Greenville Hospital System Greenville South Carolina — —
UT College of Medicine Chattanooga, Erlanger Health System Chattanooga Tennessee — —
High Risk Obstetrical Consultants, PLLC Knoxville Tennessee — —
Research Memphis Associates Memphis Tennessee — —
University of Texas Health Sciences Center at Houston Houston Texas — —
Salt Lake Women's Center, PC Sandy City Utah — —
Marshfield Clinic Research Foundation Marshfield Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01127581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01127581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →